Welcome to the weekly HLTH newsletter, your curated lens into healthcare innovation. Each week, we spotlight the trends, breakthroughs, and conversations you can’t afford to miss.
Top Story
The pharmaceutical playbook is about to be rewritten—and AI isn’t just a line of code. It’s a new line of command. With HCPs now embedding agentic AI into diagnostics, workflows, and treatment decisions, pharma faces a once-in-a-decade inflection point.
In our new whitepaper co-created with Viz.ai, learn how agentic AI is reshaping diagnostics, accelerating time-to-therapy, and creating fresh channels for engagement. Uncover what pharma needs to know now.
The FDA's decision to delay the approval of psychedelic medicines has led the VA and members of Congress to take more direct action. The FDA route may take longer than expected, so discussions in Congress and at the state level are focused on finding another path forward to get these promising treatments in the hands of Veterans in need sooner. The VA is taking a proactive approach by sponsoring research initiatives and establishing specific protocols for psychedelic studies in hopes to gain approval in the near term.
Hear from leaders within the VA and Congress on how each is working towards their shared mission to enhance the lives of Veterans.
Interested in sponsoringHLTH USA 2025?Get in touch!
Hot Off the Press
🥗 Meet Marc Lore: The Culinary Disruptor Shaping the Future of Food.
HLTH USA is where game-changers gather—and our next legendary main stage speaker for 2025 is rewriting the rulebook on food, tech, and consumer experience.
You know him as the visionary behind Jet.com and the e-commerce revolution at Walmart. Now, Marc Lore’s latest venture, Wonder, is shaking up the food industry with a never-before-seen model that’s reinventing dining, delivery, and the way we experience meals at home.
Hear how Marc is turning kitchens into next-gen platforms, and why his bold ideas are the future of food and beyond.
Digital innovation in drug development holds immense promise—but why do so many promising solutions stall before they scale? In a an exclusive report, HLTH Community and Novartis unpack the blockers slowing progress across AI, digital endpoints, decentralized trials, and more.
Drawing on 150+ digital solutions tracked over four years and insights from 21 life sciences leaders, this new report offers a sharp lens into what derails innovation—and how to course-correct.
